Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001011443-10-000029
Filing Date
2010-02-08
Accepted
2010-02-08 16:58:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 kva13ga1.txt SC 13G/A 15037
  Complete submission text file 0001011443-10-000029.txt   16911
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

EIN.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 10581497
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2101 CEDAR SPRINGS ROAD STE 700 DALLAS TX 75201
Business Address 2101 CEDAR SPRINGS ROAD STE 700 DALLAS TX 75201 2147586100
HBK INVESTMENTS L P (Filed by) CIK: 0001011443 (see all company filings)

EIN.: 752622581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A